Clariane SELTS:0OPS -3.09%61 Days Payable is 481.98 as of Dec. 2025, which is 3% below its 10-year median of 494.71. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Clariane SE ranks better than 93.23% on this metric.
The historical rank and industry rank for Clariane SE's Days Payable or its related term are showing as below:
LTS:0OPS'
s Days Payable Range Over the Past 10 Years
Min: 369.4 Med: 494.71 Max: 562.49
Current: 481.13
During the past 13 years, Clariane SE's highest Days Payable was 562.49. The lowest was 369.40. And the median was 494.71.
LTS:0OPS's Days Payable is ranked better than 93.23% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs LTS:0OPS: 481.13
Clariane SE's Days Payable
increased
from Dec. 2024 (477.18) to Dec. 2025 (481.98).
It may suggest that Clariane SEdelayed paying its suppliers.
Clariane SE Days Payable Related Terms
Clariane SE Days Payable Historical Data
* Premium members only.
The historical data trend for Clariane SE's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0OPS vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Clariane SE's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Days Payable distribution charts can be found below:
* The bar in red indicates where Clariane SE's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Clariane SE's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (LTS:0OPS) has a Days Payable of 481.98 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clariane SE and its competitors. This is near median its historical median of 494.71. Over the past decade, Clariane SE's Days Payable has ranged from 369.40 to 562.49. According to the industry distribution chart, Clariane SE ranks #41 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 6.8%.
Is Clariane SE's Days Payable too high?
Clariane SE's current Days Payable of 481.98 is near median its 10-year median of 494.71. Over the past 10 years, this metric has ranged from a low of 369.40 to a high of 562.49. The Healthcare Providers & Services industry median Days Payable is 58.21. Clariane SE's value of 481.98 is 728.1% above this industry median. Based on the distribution chart, Clariane SE ranks #41 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #41 out of 606 companies for Days Payable. This places Clariane SE in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.21. Clariane SE's value of 481.98 is 728.1% above this benchmark. Historically, Clariane SE's own Days Payable has ranged from 369.40 to 562.49 over the past decade. While the company's 10-year median is 494.71 vs. the industry median of 58.21, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current Days Payable of 481.98 is 728.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Days Payable is 481.98, which is near median its own 10-year median of 494.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current Days Payable is 481.98, which is near median its 10-year median of 494.71 and 728.1% above the Healthcare Providers & Services industry median of 58.21. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Days Payable is 481.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (LTS:0OPS) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for LTS:0OPS:
Days Payable: 481.98 (near median its 10-year median of 494.71)
GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
Industry Position: 728.1% above the Healthcare Providers & Services median (#41 of 606)
No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for LTS:0OPS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OPS has been successfully added to your 
